Main Session
Sep
27
PQA 01 - PQA 01: Gastrointestinal Cancer and Central Nervous System
2265 - Study Protocol of Neoadjuvant Concurrent Chemoradiotherapy Combined with CAPEOX and Immune Checkpoint Inhibitors for pMMR/MSS T4NanyM0 Colon Cancer: A Phase II, Prospective, Open-Label, Multi-Center, Randomized Controlled Trial(Neo-Color study)
Presenter(s)
Feng-peng Wu, MD - Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei